Literature DB >> 2889083

Atrial natriuretic peptide and blood pressure in a geographically defined population.

P Nilsson1, L Lindholm, B Scherstén, R Horn, A Melander, R D Hesch.   

Abstract

Plasma atrial natriuretic peptide (ANP) was measured in 717 subjects in a cross-sectional study of patients with hypertension (treated and untreated) and normotensive controls, representatives of a geographically defined population. ANP concentrations did not differ between the groups and there was no correlation with blood pressure. These results do not support the view that hypertensive and normotensive subjects have different ANP concentrations; they also call into question the role of ANP in the development of high blood pressure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889083     DOI: 10.1016/s0140-6736(87)91373-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Age-related antihypertensive and haemodynamic effects of verapamil SR: clinical results and effects on atrial natriuretic peptide.

Authors:  R Antonicelli; P F Tomassini; P Galletti; C Gambini; M Marini; L Amadio; E Paciaroni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

Authors:  Mahyar Khaleghi; Umer Saleem; Nils G Morgenthaler; Stephen T Turner; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-02-12       Impact factor: 2.689

3.  [Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior].

Authors:  L Neyses; J Nitsch; H P Tüttenberg; H C Korus; B Lüderitz
Journal:  Klin Wochenschr       Date:  1989-08-01

Review 4.  Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease.

Authors:  Karolina Idzikowska; Marzenna Zielińska
Journal:  J Int Med Res       Date:  2018-07-20       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.